- Allo-HSCT Improved Outcome of High Risk ALL in Pediatric-Inspired PDT-ALL-2016 CohortChen, Junjie; Wang, Zhixiang; Liu, Qifa; Zhou, Hongsheng65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Chemotherapy or Hematopoietic Stem Cell Transplantation in B-Lineage Acute Lymphoblastic Leukemia Patients Based on IKZF1 and MRD StatusDeng, Shiyu; Ou, Jiawang; Huang, Zicong; Zihong, Cai; Tang, Bingqing; Xu, Xiuli; Liu, Yiqian; Wu, Zhengwei; Liu, Qifa; Zhou, Hongsheng64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic LeukemiaTang, Bingqing; Wang, Zhixiang; Lin, Dainan; He, Xianjun; Cai, Zihong; Huang, Kangyu; Zhou, Xuan; Lin, Ren; Liu Xiaoli; Xu, Na; Huang, Fen; Sun, Jing; Liu, Qifa; Zhou, Hongsheng63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
会议论文
Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic Leukemia
13阅读
